Clinical Reminders in Test Reports to Improve Guideline Compliance

• Sponsor: VA Palo Alto Health Care System (U.S. Fed)
• Overall Status: Completed
• CT.gov ID: NCT01792544
• Collaborator: (none)
• Enrollment: 1,706
• Location: 1
• Arms: 2
• Duration (Months): 48
• Patients Per Site Per Month: 35.5

Study Details

Study Description

Brief Summary

This study examines the impact of adding a statement to the echocardiography report that advises anyone reading the report regarding if and when a follow-up study is recommended.

Condition or Disease	Intervention/Treatment	Phase
Echocardiography	Other: Statement; Other: No Statement	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 1706 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
• Primary Purpose: Health Services Research
• Study Start Date: Jul 1, 2011
• Actual Primary Completion Date: Nov 1, 2013
• Actual Study Completion Date: Jul 1, 2015

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Statement A statement is added to the echocardiography report describing if and when a follow-up echocardiogram is recommended. The statement may be positive (e.g. follow-up recommended in 6 months) or negative (e.g. no follow-up recommended).	Other: Statement
Experimental: No Statement No statement is added to the echocardiography report	Other: No Statement

Outcome Measures

Primary Outcome Measures

1. Inappropriate follow-up [1 year]

   Performance of a follow-up echocardiogram when it was not indicated or not performing for a follow-up echocardiogram when it was indicated.

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

All patients undergoing echocardiography where the physician creating the report feels a comment is appropriate regarding when follow-up should or should not occur.

Exclusion Criteria:

None.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	VA Palo Alto HCS	Palo Alto	California	United States	94304

Sponsors and Collaborators

• VA Palo Alto Health Care System

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Paul Heidenreich, Staff Physician, VA Palo Alto Health Care System
• ClinicalTrials.gov Identifier: NCT01792544
• Other Study ID Numbers: SUIRB-021780
• First Posted: Feb 15, 2013
• Last Update Posted: Apr 28, 2016
• Last Verified: Apr 1, 2016

Study Results

No Results Posted as of Apr 28, 2016